Pfizer's experimental oral drug to treat COVID-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday. The company, which developed the ...
from Google Alert - health https://ift.tt/3sZuL9C
via IFTTT
0 comments:
Post a Comment